BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34709546)

  • 21. CircRNA_100395 inhibits cell proliferation and metastasis in ovarian cancer via regulating miR-1228/p53/epithelial-mesenchymal transition (EMT) axis.
    Li X; Lin S; Mo Z; Jiang J; Tang H; Wu C; Song J
    J Cancer; 2020; 11(3):599-609. PubMed ID: 31942183
    [No Abstract]   [Full Text] [Related]  

  • 22. Knockdown of Circ_0081143 Mitigates Hypoxia-Induced Migration, Invasion, and EMT in Gastric Cancer Cells Through the miR-497-5p/EGFR Axis.
    Tang J; Zhu H; Lin J; Wang H
    Cancer Biother Radiopharm; 2021 May; 36(4):333-346. PubMed ID: 32678674
    [No Abstract]   [Full Text] [Related]  

  • 23. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
    Zhao M; Ma W; Ma C
    Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hsa_circ_0001017 promotes cell proliferation, migration and invasion in osteosarcoma by sponging miR-145-5p.
    Yang Q; Yu H; Hu K
    J Orthop Surg Res; 2022 Mar; 17(1):184. PubMed ID: 35346268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circular RNA has_circ_0000527 participates in proliferation, invasion and migration of retinoblastoma cells via miR-646/BCL-2 axis.
    Chen NN; Chao DL; Li XG
    Cell Biochem Funct; 2020 Dec; 38(8):1036-1046. PubMed ID: 32266733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circ-0001801 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition (EMT) in glioblastoma by regulating miR-628-5p/HMGB3 axis.
    Chen WL; Jiang L; Wang JS; Liao CX
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10874-10885. PubMed ID: 31858556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circ_0006948 Contributes to Cell Growth, Migration, Invasion and Epithelial-Mesenchymal Transition in Esophageal Carcinoma.
    Yue M; Liu Y; Zuo T; Jiang Y; Pan J; Zhang S; Shen X
    Dig Dis Sci; 2022 Feb; 67(2):492-503. PubMed ID: 33630215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620.
    Li X; Shen M
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(2):555-566. PubMed ID: 30720163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circ_0061140 knockdown inhibits tumorigenesis and improves PTX sensitivity by regulating miR-136/CBX2 axis in ovarian cancer.
    Zhu J; Luo JE; Chen Y; Wu Q
    J Ovarian Res; 2021 Oct; 14(1):136. PubMed ID: 34649611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis.
    Wang S; Li Z; Zhu G; Hong L; Hu C; Wang K; Cui K; Hao C
    J Ovarian Res; 2021 Nov; 14(1):154. PubMed ID: 34774079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.
    Wang L; Tong X; Zhou Z; Wang S; Lei Z; Zhang T; Liu Z; Zeng Y; Li C; Zhao J; Su Z; Zhang C; Liu X; Xu G; Zhang HT
    Mol Cancer; 2018 Sep; 17(1):140. PubMed ID: 30261900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hsa_circ_0026134 expression promoted TRIM25- and IGF2BP3-mediated hepatocellular carcinoma cell proliferation and invasion via sponging miR-127-5p.
    Zhang W; Zhu L; Yang G; Zhou B; Wang J; Qu X; Yan Z; Qian S; Liu R
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32648571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circular RNA hsa_circ_0001785 inhibits the proliferation, migration and invasion of breast cancer cells in vitro and in vivo by sponging miR-942 to upregulate SOCS3.
    Li Z; Zheng J; Lin W; Weng J; Hong W; Zou J; Zhang T; Ye C; Chen Y
    Cell Cycle; 2020 Nov; 19(21):2811-2825. PubMed ID: 33054543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of hsa_circ_0026123 suppresses ovarian cancer cell metastasis and proliferation through the miR‑124‑3p/EZH2 signaling pathway.
    Yang X; Wang J; Li H; Sun Y; Tong X
    Int J Mol Med; 2021 Feb; 47(2):668-676. PubMed ID: 33416105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circular RNA PVT1 enhances cell proliferation but inhibits apoptosis through sponging microRNA-149 in epithelial ovarian cancer.
    Sun X; Luo L; Gao Y
    J Obstet Gynaecol Res; 2020 Apr; 46(4):625-635. PubMed ID: 32048451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CircRNA_OTUD7A upregulates FOXP1 expression to facilitate the progression of diffuse large B-cell lymphoma via acting as a sponge of miR-431-5p.
    Liu W; Lei L; Liu X; Ye S
    Genes Genomics; 2021 Jun; 43(6):653-667. PubMed ID: 33830472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The novel circ_0084904/miR-802/MAL2 axis promotes the development of cervical cancer.
    Chen L; Li H; Yao D; Zou Q; Yu W; Zhou L
    Reprod Biol; 2022 Mar; 22(1):100600. PubMed ID: 35033901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hsa_circ_0009910: oncogenic circular RNA targets microRNA-145 in ovarian cancer cells.
    Li Y; Lin S; An N
    Cell Cycle; 2020 Aug; 19(15):1857-1868. PubMed ID: 32588730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
    Han L; Cheng J; Li A
    Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.